NCT02620657
Completed
Not Applicable
A Retrospective Study on Real-world EGFR Mutation Testing Practice Status and Impact Factors in Patients With Advanced NSCLC in North China
ying cheng0 sites2,809 target enrollmentDecember 2015
ConditionsNon-Small Cell Lung Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-Small Cell Lung Cancer
- Sponsor
- ying cheng
- Enrollment
- 2809
- Primary Endpoint
- To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Approximately 3000 advanced NSCLC patients, who fulfil the inclusion/exclusion criteria, will be recruited by 30 sites in North China.
Detailed Description
Approximately 3000 advanced NSCLC patients will be recruited , and the medical information of recruited patients must be recorded in the hospital electronic system from Jan 1st 2014 to Dec 31st 2014 .The study will focus on the EGFR testing rate in adenocarcinoma patients，so the collecting data for non-adenocarcinoma patients will be controlled in less than 10% for each site.
Investigators
ying cheng
Director of Jilin Cancer Hospital
Guangdong Association of Clinical Trials
Eligibility Criteria
Inclusion Criteria
- •Histological or cytological confirmed NSCLC;
- •Patients were diagnosed with advanced NSCLC from Jan 1st 2014 to Dec 31st 2014;
- •Researchers should collect the records of consecutive NSCLC patients in each site.
Exclusion Criteria
- •Any patients without NSCLC diagnosis;
- •Any patients which were diagnosed with advanced NSCLC before Jan 1st 2014 or after Dec 31st 2014.
Outcomes
Primary Outcomes
To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test
Time Frame: 2014.01.01-2014.12.31
Similar Trials
Unknown
Not Applicable
A Retrospective Molecular Epidemiology Study in Singapore Patients With Advanced Non Small Cell Lung Cancer (NSCLC) of Adenocarcinoma Histology to Assess Epidermal Growth Factor Receptor (EGFR) Mutation StatusNSCLCNCT01100827National University Hospital, Singapore
Completed
Not Applicable
EGFR Mutations on ctDNA in Patients With Advanced NSCLCNon-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer MetastaticNCT02623257First People's Hospital of Hangzhou1,055
Completed
Not Applicable
Study to Evaluate Concordance of Detecting EGFR (Epidermal Growth Factor Receptor) Mutation by Circulating Tumour Free DNA Versus Tissues Biopsy in NSCLC (Non-small Cell Lung Cancer).NSCLC (Non-small Cell Lung Cancer)NCT03562819AstraZeneca268
Unknown
Not Applicable
cSMART Liquid Biopsy and Dynamic Monitor of NSCLC Patients in Inner-Mongolia ChinaNonsmall Cell Lung CancerAdenocarcinomaNCT02980536Berry Genomics Co., Ltd.129
Completed
Not Applicable
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)Non Small Cell Lung CancerNCT01081496AstraZeneca1,000